Clinical trial
Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive…
NCT00156065 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00156065 |
|---|---|
| Title | Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) |
| Official title | A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Haloperidol Positive Control in Subjects Who Complete Protocol 041023 [NCT00156104] |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Haloperidol, Asenapine |
| Enrollment | 187 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 8, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: